drugset / Trial / NCT01792375

Concurrent Membrane Sweeping With Dinoprostone Versus Dinoprostone in Labor Induction of Nulliparas at Term With an Unfavorable Cervix

NCT01792375

Completed 192 enrolled Seoul National University Hospital
RandomizedParallel-groupOpen-labelTreatment

Summary

To compare concurrent membrane sweeping with dinoprostone versus dinoprostone in labor induction for nulliparas at term with an unfavorable cervix

Timeline

Start
2013-02
Primary completion
2018-02
Completion
2018-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dinoprostone Other / unclassified 10 mg Other

Indications

No indication recorded.